• Mashup Score: 4

    CDK4/6 inhibitors are approved to treat breast cancer and are in trials for other malignancies. We examined CDK4/6 inhibition in mouse and human CD8 T cells during early stages of activation. Mice receiving tumor-specific CD8 T cells treated with CDK4/6 inhibitors displayed increased T cell persistence and immunologic memory. CDK4/6 inhibition upregulated Mxd4, a negative regulator of Myc, in…

    Tweet Tweets with this article
    • SCI leader Nathanael Gray & colleagues discovered CDK4/6 inhibitor therapy increases the frequency of #CD8 memory precursors and downregulates expression of #MYC target genes, and may augment long-term protective immunity for #cancerpatients. https://t.co/LBqmnzdhnb #CDK4 #CDK6

  • Mashup Score: 0

    A central feature of the SARS-CoV-2 pandemic is that some individuals become severely ill or die, whereas others have only a mild disease course or are asymptomatic. Here we report development of an improved multimeric αβ T cell staining reagent platform, with each maxi-ferritin “spheromer” displaying 12 peptide-MHC complexes. Spheromers stain specific T cells more efficiently than peptide-MHC…

    Tweet Tweets with this article
    • CD8 #Tcells specific for conserved #coronavirus epitopes correlate with milder disease in #COVID__19 patients https://t.co/IsYoGNY3sD #IMMUNITY: "preferential recruitment of memory #CD8+ T cells to cross-reactive epitopes likely contributes to mild symptoms" in milder disease. https://t.co/nUrodZQcos

  • Mashup Score: 4

    The full potential of T cell-based immunotherapies remains limited by a variety of T cell extrinsic and intrinsic immunosuppressive mechanisms that can become imprinted to stably reduce the antitumor ability of T cells. Here, we discuss recent insights into memory CD8+ T cell differentiation and exhaustion and the association of these differentiation states with clinical outcomes during immune…

    Tweet Tweets with this article
    • Read the Opinion @TrendsImmuno by Caitlin C. Zebley, Stephen Gottschalk & Ben Youngblood, Rewriting History: #Epigenetic Reprogramming of #CD8+ #TCell #Differentiation to Enhance #Immunotherapy @CellCellPress #AAI2021 https://t.co/i1Al9nAsgr #immunology

  • Mashup Score: 21

    Tonsil organoids: peering down the throat of human immunityAnimal studies and explant cultures of human lymphoid tissues do not reliably model human vaccine responses. A remarkable strategy for reassociation of human tonsillar cells in ex vivo culture leads to organoid formation and provides an exciting new tool to probe human humoral immune responses to infection.Full-Text HTMLPDF …

    Tweet Tweets with this article
    • The May issue is out @TrendsImmuno!! #tonsil #organoids, #synovial #macrophages, B-ALL, mesenchymal-immune cells in #adipose tissue, #fasting & immunity, #CD8 #Tcell #metabolism & #immunity, #CRISPR in immunity & #cancer, #RNAdecay & immune #development!! https://t.co/3PClLa3Dji https://t.co/7i48DWHbe6

  • Mashup Score: 0

    Memory T cells (Tmem) rapidly mount Ag-specific responses during pathogen reencounter. However, Tmem also respond to inflammatory cues in the absence of an activating TCR signal, a phenomenon termed bystander activation. Although bystander activation was first described over 20 years ago, the physiological relevance and the consequences of T cell bystander activation have only become more evident…

    Tweet Tweets with this article
    • Newest #BriefReview: The Ugly Duckling Turned to Swan: A Change in Perception of Bystander-Activated Memory CD8 T Cells https://t.co/RFJBssQ4yW #ReadtheJI #immunology #cd8 #tcells https://t.co/WSTIu3P8Fv

  • Mashup Score: 2

    CD8+ T cell immunological memory of past antigen exposure can confer long-lived protection against infections or tumors. The fact that CD8+ memory T cells can have features of both naïve and effector cells has forced the field to struggle with several conceptual questions about the developmental origin of the cell and, consequently, the mechanism(s) that contribute to memory development. Here, we…

    Tweet Tweets with this article
    • Read the Opinion @TrendsImmuno on #Stem, #Effector, and #Hybrid States of #Memory #CD8 #TCells in #Cancer, by Enrico Lugli, Giovanni Galletti, Shannon K. Boi & Ben Youngblood https://t.co/6MdBdDJHnl #cellbio2020 https://t.co/VFGVUutk63